Akums Drugs and Pharmaceuticals shareholders and shareholding pattern

NSE: AKUMSBSE: 544222Pharmaceuticals & BiotechnologySmall Cap

₹669.00₹11.20 (1.65%)BSE ₹668.10

Share price at the NSE close on 23 Oct 2026. Previous close ₹680.20.

52-week range of traded prices to 23 Oct 2026

₹409.30Low, 21 Jan 2026₹838.80High, 23 Sep 2026

Market cap: ₹10,530 Cr630th largest listed
P/E: 36.1
P/B: 3.2
Dividend yield: 0.45%
ROE: 9.2%
ROCE: 12.0%
Debt to equity: 0.02
Volume, NSE: 1,89,38152.3% delivered

Who owns Akums Drugs and Pharmaceuticals, filing by filing

Per cent of the company's shares. Every filing on record, from Sep 2024; the latest is the filing for Sep 2026.

Sep 2026 filing

Promoters75.26%
Foreign institutions4.50%
Indian institutions11.08%
Individuals and others6.43%
Employee trusts2.73%

Shareholding pattern, per cent

Promoters
Foreign institutions
Indian institutions
Individuals and others
Employee trusts

Per cent	Sep 2024Filed 16 Oct	Dec 2024Filed 11 Jan	Mar 2025Filed 9 Apr	Jun 2025Filed 17 Jul	Sep 2025Filed 15 Oct	Dec 2025Filed 12 Jan	Mar 2026Filed 7 Apr	Jun 2026Filed 18 Jul	Sep 2026Filed 12 Oct
	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%
Indian promoters	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%	75.26%
	22.01%	22.01%	22.01%	22.01%	22.01%	22.01%	22.01%	22.01%	22.01%
	7.34%	6.36%	5.77%	4.24%	2.28%	1.15%	1.37%	1.91%	4.50%
Foreign portfolio investors, category I	7.01%	6.33%	5.71%	4.12%	2.11%	1.14%	1.35%	1.66%	3.55%
Foreign portfolio investors, category II	0.33%	0.03%	0.06%	0.12%	0.16%	Under 0.01%	0.03%	0.25%	0.95%
	7.52%	7.00%	7.40%	8.85%	9.28%	14.40%	14.35%	13.44%	11.08%
Mutual funds	5.18%	5.54%	6.11%	6.73%	6.44%	11.23%	10.95%	9.77%	7.58%
Insurance companies	1.72%	0.67%	0.66%	0.61%	0.63%	0.65%	0.60%	0.37%	0.12%
Alternative investment funds	0.35%	0.50%	0.62%	1.51%	2.21%	2.53%	2.81%	3.30%	3.39%
Non-bank lenders registered with RBI	0.28%	0.28%	0.00%	–	–	–	–	–	–
	7.15%	8.65%	8.85%	8.93%	10.46%	6.46%	6.29%	6.66%	6.43%
Resident individuals, up to ₹2 lakh at face value	1.91%	3.33%	3.41%	3.52%	4.60%	5.22%	5.05%	5.26%	4.90%
Resident individuals, over ₹2 lakh at face value	0.19%	0.00%	0.00%	0.08%	0.41%	0.29%	0.29%	0.31%	0.31%
Companies	0.22%	0.48%	0.55%	0.36%	0.43%	0.50%	0.50%	0.52%	0.60%
Non-resident Indians	0.04%	0.05%	0.07%	0.08%	0.11%	0.14%	0.17%	0.24%	0.27%
Foreign companies	4.62%	4.62%	4.62%	4.62%	4.62%	–	–	–	0.00%
Directors and their relatives	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
Key managers	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%
	0.16%	0.16%	0.19%	0.26%	0.29%	0.30%	0.28%	0.34%	0.34%
Clearing Members	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%	0.01%	0.01%	0.01%	0.05%
Hindu undivided families	0.15%	0.14%	0.14%	0.20%	0.23%	0.23%	0.19%	0.24%	0.21%
LLP	0.01%	0.02%	0.04%	0.05%	0.06%	0.07%	0.07%	0.08%	0.07%
Trusts	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	Under 0.01%	0.01%	0.02%
Employee trusts	2.73%	2.73%	2.73%	2.73%	2.73%	2.73%	2.73%	2.73%	2.73%
Shares in issue	15,73,93,988	15,73,93,988	15,73,93,988	15,73,93,988	15,73,93,988	15,73,93,988	15,73,93,988	15,73,93,988	15,73,93,988
Shares locked in	13,18,36,871	12,57,33,915	3,14,78,800	3,14,78,800	3,14,78,800	3,14,78,800	–	–	–
Promoters' shares locked in	11,84,55,380	11,84,55,380	3,14,78,800	3,14,78,800	3,14,78,800	3,14,78,800	–	–	–

A dash is a line the filing did not state. “Under 0.01%” is a holding of shares too small to show at two decimals.

Number of Akums Drugs and Pharmaceuticals shareholders

Shareholders on the company's register in each filing.

Shareholders, filing by filing

Shareholders	Sep 2024Filed 16 Oct	Dec 2024Filed 11 Jan	Mar 2025Filed 9 Apr	Jun 2025Filed 17 Jul	Sep 2025Filed 15 Oct	Dec 2025Filed 12 Jan	Mar 2026Filed 7 Apr	Jun 2026Filed 18 Jul	Sep 2026Filed 12 Oct
All shareholders	57,531	68,410	69,366	69,424	75,365	76,869	72,589	70,289	67,618
	4	4	4	5	5	5	5	4	4
Indian promoters	4	4	4	5	5	5	5	4	4
	57,526	68,405	69,361	69,418	75,359	76,863	72,583	70,284	67,613
	46	33	50	55	45	20	21	33	91
Foreign portfolio investors, category I	41	31	43	47	36	17	18	27	81
Foreign portfolio investors, category II	5	2	7	8	9	3	3	6	10
	26	29	29	30	29	27	23	34	39
Mutual funds	9	16	18	18	16	16	9	12	12
Insurance companies	11	7	6	6	6	4	3	3	2
Alternative investment funds	5	5	5	6	7	7	11	19	25
Non-bank lenders registered with RBI	1	1	0	–	–	–	–	–	–
	57,454	68,343	69,282	69,333	75,285	76,816	72,539	70,217	67,483
Resident individuals, up to ₹2 lakh at face value	55,694	66,234	67,137	67,013	72,767	74,139	69,886	67,165	64,383
Resident individuals, over ₹2 lakh at face value	2	0	0	1	2	1	1	1	1
Companies	113	193	197	219	209	255	252	359	376
Non-resident Indians	233	351	381	454	528	595	666	885	1,006
Foreign companies	1	1	1	1	1	–	–	–	0
Directors and their relatives	1	1	1	1	1	1	1	1	1
Key managers	2	2	2	2	2	2	2	2	2
	1,408	1,561	1,563	1,642	1,775	1,823	1,731	1,804	1,714
Clearing Members	2	3	1	1	17	12	15	15	17
Hindu undivided families	1,384	1,526	1,534	1,614	1,723	1,767	1,674	1,735	1,643
LLP	20	31	27	24	33	43	41	51	50
Trusts	2	1	1	3	2	1	1	3	4
Employee trusts	1	1	1	1	1	1	1	1	1

A dash is a line the filing did not state.

Akums Drugs and Pharmaceuticals promoters

Promoters are the founders, families and companies that control the company, as its filings name them. Every member of the promoter group holding shares in the filing for Sep 2026; the largest is AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain), 40.79%. The filing names 26 more members with no shares.Promoter buying and selling

Holder
AKUMS MASTER TRUST (Sanjeev Jain and Sandeep Jain)Indian companies, trusts and others	40.79%	6,42,00,000
Sandeep JainIndividuals and Hindu undivided families	17.24%	2,71,27,690
Sanjeev JainIndividuals and Hindu undivided families	17.23%	2,71,13,940
Lata JainIndividuals and Hindu undivided families	0.01%	13,750

No promoter shares are reported as pledged.

Largest public holders of Akums Drugs and Pharmaceuticals, filing by filing

Per cent, on the same shares as the split above.Mutual funds holding Akums Drugs and Pharmaceuticals

Holder	Sep 2024Filed 16 Oct	Dec 2024Filed 11 Jan	Mar 2025Filed 9 Apr	Jun 2025Filed 17 Jul	Sep 2025Filed 15 Oct	Dec 2025Filed 12 Jan	Mar 2026Filed 7 Apr	Jun 2026Filed 18 Jul	Sep 2026Filed 12 Oct
Clarus Capital IAlternative investment funds	–	–	–	–	1.30%	1.80%	1.96%	2.17%	2.23%
Ruby Qc Investment Holdings Pte LtdForeign companies	4.62%	4.62%	4.62%	4.62%	4.62%	–	–	–	–
Smallcap World Fund, IncForeign portfolio investors, category I	2.15%	2.15%	1.69%	–	–	–	–	–	–

A filing names every holder above one per cent, in the company's own words: an insurer's holding can carry one of its funds' names. Mutual funds are left out here: each fund's holding is on the Mutual funds tab, from its own portfolio. A dash is a filing that did not name the holder, which includes holding under one per cent.